CKM Syndrome Prevalence and Its Association With SCORE-2 and BRI
NCT06944236
Cardiovascular Diseases, Chronic Disease
Gaziantep, Turkey (Türkiye)
View Trial DetailsNCT Number: NCT06865456
In recent years, the global prevalence of diabetes has risen significantly. According to the 9th edition of the International Diabetes Federation Atlas, an estimated 463 million adults were living with diabetes in 2019, representing approximately 9.3% of the population, with an average annual increase of 51%.
Diabetes is associated with multiple complications that can significantly impact patient outcomes . In 2019 alone, around 4.2 million deaths were attributed to diabetes and its complications, accounting for approximately 11.3% of all global deaths .
In diabetic patients, several factors influence renal survival, including glycemic control, blood pressure management, lifestyle interventions, and pharmacological therapies such as renin-angiotensin-aldosterone system (RAAS) inhibitors, sodium-glucose co-transporter-2 (SGLT2) inhibitors, and glucagon-like peptide-1 (GLP-1) receptor agonists(9). Early detection of kidney dysfunction through biomarkers like estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (UACR) plays a pivotal role in improving renal outcomes.
This study aims to evaluate the factors affecting Patients survival in diabetic patients, identify early predictors of renal function decline, and assess the effectiveness of current therapeutic strategies.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: baseline
pergentage of diabetic patients with stage 4,5 chronic kidney disease
Assiut University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06944236
Cardiovascular Diseases, Chronic Disease
Gaziantep, Turkey (Türkiye)
View Trial DetailsNCT06855992
Chronic Disease, Chronic Kidney Disease(CKD)
View Trial DetailsNCT06879223
Chronic Disease, Chronic Kidney Disease(CKD)
Giza, Egypt
View Trial DetailsNCT06807567
Chronic Disease, Chronic Kidney Disease(CKD)
Blantyre, Malawi
View Trial Details